The Noonan syndrome is a rare disorder, one of whose major complications is cardiovascular involvement. A wide spectrum of congenital heart diseases has been observed in this syndrome. 
Introduction
The Noonan syndrome is a rare disorder with diverse body organs involvement and one of the main organs that involved in this syndrome is cardiovascular system.
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The most common cardiac disorder is pulmonary valve stenosis, which has a progressive nature. Hypertrophic cardiomyopathy is less common. The Noonan syndrome is a genetic disorder that usually was observed as sporadic pattern but autosomal transmission also was seen. Because the cardiac diseases have progressive nature in Noonan syndrome development of cardiac symptoms and signs necessitate careful cardiac evaluation and prompt treatment.
1, 2

Case Report
A 12-year-old boy was admitted to our hospital due to shortness of breath, exertional dyspnea, and exercise intolerance. Based on his past medical history as an infant, the 1st signs had begun when he was 4 months old by bluish discoloration of the lips, lethargy, and poor feeding. His mother declared that her child suffered from inguinal hernia but that he had no other disease. He had another sibling, who was healthy. There was no family history of congenital cardiac disease or sudden cardiac death.
Gradually as the patient grew up, his symptoms increased and mere usual childhood activities let to dyspnea and fatigue. On physical examination, short stature, failure to thrive, and chest wall deformity were noted. Additionally, he had special facial characteristics such as low-set ears, ptosis, hypertelorism, and low posterior hairline (Figure 1 ). Multiple lentigines were observed on his face, trunk, and extremities as well. Cardiac auscultation findings included normal 1st heart sound, single 2nd sound, and a grade 4/6 systolic murmur at the left sternal border. Chest X-ray revealed an increased cardiothoracic ratio and a decreased pulmonary vascular marking. The laboratory test was normal except for iron deficiency anemia (hemoglobin = 10.2 g/L). Electrocardiography (ECG) yielded evidence of biventricular hypertrophy, biatrial enlargement, and ST-T change. The family showed us another ECG trace of his infantile period, which also propounded hypertrophic cardiomyopathy (HCM). Medical treatment with propranolol and captopril was recommended. The patient, however, failed to consume these drugs regularly. Due to severe pulmonary valve stenosis, percutaneous pulmonary balloon valvuloplasty was done 1 year before the present article was written, but there was no significant decrease in the pressure gradient via the pulmonary valve. Because the patient's symptoms and signs were progressive and there was no proper response to drug therapy, he was considered for surgical repair. During surgery, via a right ventricular outflow tract incision, the outflow tract muscle was shaved and the pulmonary valve was repaired. Also, septomyomectomy was done in the left ventricular outflow tract (LVOT) region. After surgery, in the intensive care unit, the patient had a devastating postoperative course. A combination of low cardiac output, disseminated intravascular coagulation, and ischemic pattern due to HCM and frequent arrhythmia deteriorated his condition. His condition was further exacerbated by gastrointestinal bleeding and bleeding from the chest tube. Acidosis and electrolyte imbalance were corrected, and inotropes and broad-spectrum antibiotics were prescribed. He then developed junctional ectopic tachycardia, which was treated with intravenous amiodarone. Gradually, however, his general condition improved. At the time of his discharge, echocardiography revealed better LV systolic function (LV ejection fraction = 45%), reduced pressure gradient via the pulmonary valve (60 mmHg), and a 10 mmHg pressure gradient between the LVOT and the aortic valve. At 3 months' follow-up, his functional class showed a significant improvement, as confirmed by the exercise test.
Our patient has a single major pediatric risk factor (maximum LV wall thickness ≥ 30 mm), which is class IIb for the implantation of the implantable cardioverterdefibrillator (ICD). Nonetheless, in the future, he may be candidated for ICD implantation and may, as such, need very careful observation.
Discussion
The Noonan syndrome is a rare but well-recognized genetic syndrome, and cardiovascular disorder is one of its major complications. The incidence of the Noonan syndrome is between 1,000 and 2,500 in live births. [3] [4] [5] The Noonan syndrome is a heterogeneous genetic syndrome, but mutation in the PTPN11 gene on chromosome 12 has been found in approximately 50% of the patients. 6 The syndrome usually has a sporadic pattern, but autosomal dominant transition has also been reported. 7 Owing to multiple organ involvement, a wide spectrum of symptoms and signs may occur in this syndrome (Table 1) 8, 9 and most patients are referred for medical management during infancy and childhood.
Most patients with the Noonan syndrome have cardiac abnormalities, which predominantly present as congenital heart defects, cardiomyopathy, arrhythmia, or a combination of all. Pulmonary valve stenosis is the most common congenital heart defect. 10 The pulmonary valve may be dysplastic and malformed, and it may be accompanied by subvalvular stenosis.
11 In a study by Marino et al. 12 on 136 patients with the Noonan syndrome, pulmonary stenosis was reported in 39% of the patients. Although HCM in the Noonan syndrome is less common, its morbidity rate is high. The association between HCM in the Noonan syndrome and sudden cardiac death and heart failure necessitates an exact evaluation. HCM presents in earlier age often during infancy, and LVOT obstruction is also common (average gradient = 32 mmHg). 13, 14 In our patient, the presenting sign was cardiac involvement, beginning during infancy. A combination of pulmonary valve stenosis, a usual cardiac sign in the Noonan syndrome, and HCM rendered the management of this patient very difficult. We tried in vain to eliminate the pulmonary valve stenosis with balloon valvuloplasty, which seemed reasonable given the dysplastic valve morphology and stenosis in the subvalvular region. On the other hand, HCM with its progressive nature led to severe diastolic and systolic dysfunction, which together with right ventricular systolic and diastolic dysfunction lessened the functional class and exercise tolerance and-in short-caused an almost intolerable condition for the child. In a study by Poterucha et al., 15 surgical myectomy in patients with the Noonan syndrome and HCM with LVOT obstruction decreased the LVOT gradient and the New York Heart Association's class. These results are similar to those reported in patients with nonsyndromic HCM.
Although we expected the patient's bad course in the early postoperative period, the addition of sepsis to low cardiac output state after surgery made this condition even worse than was expected. With appropriate treatment, the patient's cardiac function and general condition gradually improved. The next step in the management of this patient is the decision-making for ICD insertion. 16 
Conclusion
The cardiovascular involvement in the Noonan syndrome has a progressive and often life-threatening course. We recommend a comprehensive evaluation for cardiovascular disorders, especially pulmonary valve involvement and HCM, in children with the Noonan syndrome. Repair of cardiovascular disorders in earlier age before severe injury to the right ventricular and LV myocardium may prevent postsurgical complications and long-term hospitalization.
